Eitan Rubinstein | Medical Services
Specialties
Programs & Services
- Aerodigestive Center
- Eosinophilic Gastrointestinal Disease Program
- Feeding and Swallowing Program
- Gastroenterology, Hepatology and Nutrition
Languages
- English
- Spanish
Eitan Rubinstein | Education
Undergraduate School
University of California San Diego
1999, San Diego, CA
Medical School
University of Southern California School of Medicine
2003, Los Angeles, CA
Internship
Pediatric Primary Care
Boston Combined Residency Program (BCRP)
2004, Boston, MA
Residency
Pediatric Primary Care Track
Boston Combined Residency Program (BCRP)
2006, Boston, MA
Fellowship
Pediatric Gastroenterology, Hepatology, and Nutrition
University of California
2010, San Diego, CA
Eitan Rubinstein | Certifications
- American Board of Pediatrics (Gastroenterology)
Eitan Rubinstein | Publications
The role of dupilumab in the treatment of eosinophilic esophagitis. Immunotherapy. 2024; 16(13):845-852. View The role of dupilumab in the treatment of eosinophilic esophagitis. Abstract
Characterization of Eosinophilic Esophagitis in Infants and Toddlers. J Pediatr Gastroenterol Nutr. 2023 07 01; 77(1):86-92. View Characterization of Eosinophilic Esophagitis in Infants and Toddlers. Abstract
Real World Experience With Dupilumab in Eosinophilic Esophagitis in Children and Young Adults at a Tertiary Care Pediatric Medical Center. JPGN Rep. 2022 May; 3(2):e180. View Real World Experience With Dupilumab in Eosinophilic Esophagitis in Children and Young Adults at a Tertiary Care Pediatric Medical Center. Abstract
Oral viscous mometasone is an effective treatment for eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2020 Mar; 8(3):1107-1109. View Oral viscous mometasone is an effective treatment for eosinophilic esophagitis. Abstract
Respiratory symptoms associated with eosinophilic esophagitis. Pediatr Pulmonol. 2018 11; 53(11):1587-1591. View Respiratory symptoms associated with eosinophilic esophagitis. Abstract
Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis. J Pediatr Gastroenterol Nutr. 2018 03; 66(3):395-397. View Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis. Abstract
Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2014 Sep; 59(3):317-20. View Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. Abstract
Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC Gastroenterol. 2014 Apr 09; 14:71. View Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. Abstract
The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Pediatr Pulmonol. 2014 Nov; 49(11):1090-6. View The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Abstract
Topical inhaled ciclesonide for treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2012 Oct; 130(4):1011; author reply 1011-2. View Topical inhaled ciclesonide for treatment of eosinophilic esophagitis. Abstract
Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2011 Oct; 53(4):409-16. View Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. Abstract
Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis. 2008 Nov; 28(4):380-5. View Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Abstract